ESPID Education. Givon-Lavi N. Jun 7, 2011; 7711
Dr. Noga Givon-Lavi
Dr. Noga Givon-Lavi

This content is available to ESPID members only

Click here for more information or if you are considering becoming an ESPID member.

Discussion Forum (0)
Rate & Comment (0)
Background and aims: PCV7 was licensed in Israel in 2007, with scattered use till 2009, and was introduced to the Israeli NIP in July 2009, as a 2, 4, 12m schedule, with catch-up (2 doses, 2nd year). IPD nationwide active surveillance has been conducted since 1989.
Methods: All 27 medical centers performing blood cultures in Israel participated by reporting monthly all IPD cases (defined by positive blood/CSF cultures). Capture-recapture methods were used to evaluate completeness. ~50% of isolates were submitted to serotyping until recent years, and >95% since 2000. Extrapolation by year, ethnic group, age, and serogroups was conducted to insure appropriate age-specific serotype-specific incidence assessment.
Results: During 1989-2010, 6,022 cases were reported. PCV7 serotypes+6A (VT) contributed ~50% of IPD. VT increased during 1989-2008, contributing to overall IPD increase. In 2004-8, mean IPD incidence/100,000 was 50 and 89 for <5 and <2 years, respectively. In 2010, VT incidence decreased by 80% and 85% compared with 2004-8 in <5 and <2 years respectively, (P<0.001). The respective overall IPD reduction was 41% and 45% with no replacement so far. In 2010, 72% of isolates causing remaining IPD <5 years were PCV13 serotypes.
Conclusions: PCV7 introduction to NIP as a 2+1 schedule with catch-up in <2 years, showed a rapid decrease in IPD <5 yrs. PCV7 was replaced by PCV13 since November 2010.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings